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Regulation of the myo-inositol and betaine cotransporters by tonicity.
Cells of the hypertonic renal medulla accumulate high concentrations of
the non-perturbing osmolytes myo-inositol, betaine, and taurine, and are
thereby protected from the perturbing effects of hypertonicity. Kidney-
derived MDCK cells accumulate high levels of these three non-perturbing
osmolytes when cultured in hypertonic medium and have been used to
study their accumulation. The increase in the intracellular concentration
of these non-perturbing osmolytes is the result of an increase in the
abundance of the mRNA for the specific cotransporter for each osmolyte
and the ensuing increase in the activity of the three specific sodium
coupled transporters. The increased abundance of mRNA for the myo-
inositol and the betaine cotransporters is driven by an increase in the rate
of transcription of their genes. We have identified a 13 basepair cis-acting
element in the 5' flanking region of the gene for the betaine cotransporter.
The element is an enhancer that mediates the transcriptional response to
hypertonicity. The protein(s) that binds to the tonicity responsive element
is much more active in hypertonic than in isotonic cells, and is in all
likelihood the mediator of the transcriptional response to changes in
tonicity.
In virtually all species, cells employ the same fundamental
strategy in response to the stress of hypertonicity. Rather than
suffer the perturbing effects of the elevation of cell electrolyte
concentration required to osmotically balance extracellular hyper-
tonicity, almost all bacteria, plants, and animal cells maintain their
electrolyte concentration similar to that of cells in an isotonic
medium by balancing the additional extracellular tonicity by
accumulating certain small organic solutes that, in contrast to high
concentrations of electrolytes, do not perturb the function of
macromolecules. The characteristics and biologic distribution of
non-perturbing or compatible osmolytes were summarized by
Yancey and Somero and colleagues in 1982 in a seminal review
[1]. The mechanism of perturbation or compatibility has been
considered recently [21.
Because of the marked changes in tonicity that the renal
medulla experiences as part of he mechanism of urinary dilution
or urinary concentration, many renal physiologists have studied
the accumulation and loss of compatible osmolytes by kidney cells.
We have focused on compatible osmolytes accumulated by trans-
port. Following the lead of the NIH group [3], we work with
MDCK cells, derived from an unknown site in canine kidney.
When cultured in a hypertonic medium, MDCK cells accumulate
high concentrations of myo-inositol, betaine [3], and taurine [4] by
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increasing the activity of a specific sodium coupled transporter for
each. The importance of the uptake of the three compatible
osmolytes in hypertonic medium was evident when their uptake
was prevented by removing them from the medium in which
MDCK cells were cultured. Absence of the osmolytes had no
discernible effect on the ability of MDCK cells to form colonies in
isotonic medium. Colony formation was markedly impaired, how-
ever, in hypertonic medium unless at least one of the three
osmolytes was present in the medium [4]. The experiment also
demonstrates the inability of MDCK cells to synthesize osmopro-
tective amounts of any of those three compatible osmolytes. All
three cotransporters are located in the basolateral plasma mem-
brane of MDCK cells [5], which implies that uptake in situ is
primarily from the interstitium rather than from tubule fluid, but
that extrapolation from studies of cultured cells has not been
tested in tubules.
Early studies indirectly testing for the level of mRNA for each
cotransporter by comparing the expression of po1yARNA
(mRNA) from isotonic versus hypertonic MDCK cells suggested
that the increase in activity of each of the cotransporters was the
result of an increase in the abundance of their mRNA [6—8]. To
gain a more fundamental understanding of regulation by hyper-
tonicity we used expression cloning in oocytes and used the cloned
cDNAs to confirm that hypertonicity elevated the abundance of
their mRNAs in MDCK cells [9—11]. Along the same line, the
mRNA for the three cotransporters is expressed most abundantly
in the hypertonic renal medulla [9—11]. Studies in mammals
indicate that the accumulation of myo-inositol, betaine, and
taurine is increased in hypertonic renal medulla [12—14]. We
focused our subsequent efforts on the MDCK cell myo-inositol
and betaine cotransporters whose activity goes up more than
fivefold in cells shifted to hypertonic medium. The activity of the
taurine cotransporter is high in MDCK cells in isotonic medium
and increases by only 50% in cells in hypertonic medium [4].
Nuclear run-on assays established that the increase in mRNA
abundance for the two cotransporters in hypertonic cells is the
result of an increase in transcription of their genes, transcription
and mRNA abundance having very similar time courses when
cells are switched from isotonic to hypertonic medium or from
hypertonic to isotonic medium [15, 16]. We have no evidence that
tonicity affects the stability of the mRNA for either cotransporter.
To understand the mechanism of the very specific increase in
transcription of the cotransporter genes, we cloned the two genes
and analyzed their structure [17; Rim, Preston, Takenaka, Han-
dler, and Kwon, unpublished observations]. The canine betaine
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cotransporter gene has a 13 basepair element 5' to the first exon
that conveys a hypertonicity inducible increase in transcription to
its own or a heterologous promoter in MDCK cells. That same 13
basepair element binds a nuclear protein that is far more abun-
dant in hypertonic than in isotonic MDCK cells and in several
tests has all the characteristics of an enhancer element that
mediates the transcriptional stimulation seen in hypertonic
MDCK cells [18]. We have named that tonicity responsive ele-
ment, TonE. Currently, we are cloning the cDNA for the nuclear
protein that binds to the tonicity responsive element and search-
ing for an element that performs the same function for the gene
for the myo-inositol cotransporter.
Recently, we identified more acute, post-translational regula-
tion of the myo-inositol and the betaine cotransporters. Both
proteins include consensus sequences for phosphorylation by
protein kinase A (PKA) and protein kinase C (PKC) [9, 10].
Activation of either kinase results in 30% inhibition of the activity
of both cotransporters. The effects of the two kinases are not
additive. Also, the degree of inhibition is not dependent on
tonicity, that is, activity is inhibited by about 30% in hypertonic
and in isotonic cells. The two cotransporters respond differently
when PKC is down-regulated by prolonged exposure to an active
phorbol ester. Activity of the myo-inositol cotransporter increases
by 150% whereas the activity of the betaine cotransporter is not
affected [19]. Understanding the molecular basis of the action of
the protein kinases will require determination of the state of
phosphorylation of the cotransporter proteins, a determination
that requires the development of suitable antibodies. The effect of
the kinases may be important in the renal medulla whose cells
respond to a variety of hormonal signals by activation of one or
both kinases.
An important question is how cells sense change in the tonicity
of their environment. We have recently studied a line of cells
derived from a human malignant melanoma [20]. The cancer cells
exhibit frequent blebbing at their plasma membrane. They lack
actin binding protein 280 (ABP28O). Genetic correction of the
defect in ABP28O by transfection with the cDNA for ABP28O
corrects the abnormal blebbing. The uncorrected cells display a
weak response after 24 hours of hypertonicity in that the activity
of their myo-inositol cotransporter only doubles. The activity of
the cotransporter in the corrected melanoma cells increases
several-fold when they are shifted to hypertonic medium. Thus a
single defect in the cytoskeleton markedly disturbs the cell's
response to hypertonicity. The link between the cytoskeleton and
the response remains to be determined.
Regulation of the accumulation of compatible osmolytes is
complex. Accumulation is regulated by tonicity, the activity of
protein kinases, and the availability of other compatible osmolytes
[21].
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